翰森制药完成发行46.8亿港元零息可换股债券

Core Viewpoint - Hansoh Pharmaceutical (03692) announced the proposed issuance of HKD 4.68 billion zero-coupon convertible bonds maturing in 2033, with all conditions for the bond issuance having been met and successfully implemented on February 3, 2026 [1] Group 1 - The company has received approval for the listing and trading of the convertible bonds on the Hong Kong Stock Exchange [1] - The bonds are expected to be listed and traded on the Vienna MTF operated by the Vienna Stock Exchange on or around February 4, 2026 [1]